Richter Capacity Grows Further With KV Licensing Deal

Hungary-based Gedeon Richter has acquired licensing rights to a number of technology platforms and women's health products from US speciality firm KV Pharmaceutical. Richter will be authorised to manufacture present in-licensed products and its own proprietary drugs using KV technology and market them across Europe, including all EU member states. Financial terms were

To read the full article, please choose one of the following options: